Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of the Endocrine Society|May 5, 2021
Thyroid Eye Disease: Navigating the New Treatment LandscapeChrysoula Dosiou, Andrea Lora KosslerEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 24, 2025
Thyroid Eye Disease: Management, Advances, and Future OpportunitiesTamaryn Fox, Andrea Lora Kossler, Chrysoula DosiouThe Journal of Clinical Endocrinology and Metabolism|November 8, 2022
Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye DiseaseAndrea Lora Kossler, Raymond Douglas, Chrysoula DosiouCurrent Opinion in Ophthalmology|August 9, 2019
Neurostimulation for tear productionJi Kwan Park, Sandra Cremers, Andrea Lora KosslerOphthalmic Plastic and Reconstructive Surgery|October 15, 2021
Corneal Neurotization via Dual Nerve AutograftingEmily Sarah Charlson, John Paul Pepper, Andrea Lora KosslerThe Journal of Clinical Endocrinology and Metabolism|October 17, 2022
New Onset or Deterioration of Thyroid Eye Disease After mRNA SARS-CoV-2 Vaccines: Report of 2 Cases and Literature ReviewAbubakr Mohamed, Ploutarchos Tzoulis, Andrea Lora Kossler, et al.The Journal of Clinical Endocrinology and Metabolism|October 27, 2022
Teprotumumab-Related HyperglycemiaLinus Amarikwa, Abubakr Mohamed, Sun H Kim, et al.Ophthalmic Plastic and Reconstructive Surgery|March 6, 2023
Reduction of Teprotumumab-Induced Hearing Loss With Comparable Efficacy Using Half-Dose TherapyRagini Phansalkar, Tracy Lu, Jennifer Alyono, et al.Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 1, 2021
Microphthalmia and orbital cysts in DiGeorge syndromeArthika Chandramohan, Connie Martin Sears, Laura C Huang, et al.Eye (London, England)|December 26, 2025
Ocular adverse effects of bisphosphonates and association with osteonecrosis from a real-world databaseSamuel H Kim, Ehsan Rahimy, Euna B Koo, et al.Pageof 2